Effect of Oral L-Citrulline on Peripheral and Central Endothelial Function in Young and Older Adults
This phase 1 study aims to evaluate how oral L-Citrulline affects brain activity and blood flow in the brain and retina of both young and older adults, by measuring changes in neuronal activity, neurovascular coupling using functional near infrared spectroscopy (fNIRS), and dynamic retinal vessel analysis before and after treatment.
L-Citrulline, capsule
Basic Science Study
Summary
Study start date: January 3, 2024
Actual date on which the first participant was enrolled.This study explores how a substance called L-Citrulline affects blood vessel function in both young and older adults. L-Citrulline is a compound that our bodies can convert into another substance called nitric oxide (NO), which is crucial for regulating blood pressure and blood flow, and maintaining overall vascular health. As we age, our bodies tend to produce less nitric oxide, especially if we're not very active. While L-Citrulline's effects on muscle strength, endurance, and blood vessel function in various health conditions are well-studied, its impact on brain blood vessels is not well understood. During this study, participants will take L-Citrulline orally. Researchers will then measure changes in brain activity and blood flow using techniques like EEG, functional near-infrared spectroscopy (fNIRS), and dynamic retinal vessel analysis. These measurements will be taken before and after treatment to see if L-Citrulline makes a difference. Results will be reported as a percentage change from the starting point. The potential risks and benefits of L-Citrulline on brain blood vessel function could provide valuable insights into how we can maintain vascular health as we age.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 90 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location